0000899243-21-024531.txt : 20210617 0000899243-21-024531.hdr.sgml : 20210617 20210617195518 ACCESSION NUMBER: 0000899243-21-024531 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morrison Jodie Pope CENTRAL INDEX KEY: 0001618247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 211026637 MAIL ADDRESS: STREET 1: C/O TOKAI PHARMACEUTICALS, INC. STREET 2: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-15 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001618247 Morrison Jodie Pope C/O AILERON THERAPEUTICS, INC. 285 SUMMER STREET, SUITE 101 BOSTON MA 02210 1 0 0 0 Stock Option (right to buy) 1.29 2021-06-15 4 A 0 96000 0.00 A 2031-06-14 Common Stock 96000 96000 D This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders. /s/ Rick Wanstall, attorney-in-fact for Jodie Pope Morrison 2021-06-17